Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment
- 24 June 2011
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 18 (6), 777-793
- https://doi.org/10.1016/j.chembiol.2011.04.012
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2CNature Genetics, 2009
- Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2CNature Genetics, 2009
- TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP+Cell Calcium, 2009
- Calcium signaling and neurodegenerative diseasesTrends in Molecular Medicine, 2009
- Ginsenosides protect striatal neurons in a cellular model of Huntington's diseaseJournal of Neuroscience Research, 2009
- Motor Deficit in a Drosophila Model of Mucolipidosis Type IV due to Defective Clearance of Apoptotic CellsCell, 2008
- Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's diseaseNeurobiology of Disease, 2008
- Formation of a new receptor‐operated channel by heteromeric assembly of TRPP2 and TRPC1 subunitsEMBO Reports, 2008
- Transcriptional signatures in Huntington's diseaseProgress in Neurobiology, 2007
- Huntingtin inhibits caspase-3 activationThe EMBO Journal, 2006